JP2014177492A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2014177492A5 JP2014177492A5 JP2014133867A JP2014133867A JP2014177492A5 JP 2014177492 A5 JP2014177492 A5 JP 2014177492A5 JP 2014133867 A JP2014133867 A JP 2014133867A JP 2014133867 A JP2014133867 A JP 2014133867A JP 2014177492 A5 JP2014177492 A5 JP 2014177492A5
- Authority
- JP
- Japan
- Prior art keywords
- desmopressin
- serum
- plasma
- prevention
- pharmaceutically acceptable
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 108010000437 Deamino Arginine Vasopressin Proteins 0.000 claims 16
- NFLWUMRGJYTJIN-NXBWRCJVSA-N desmopressin Chemical compound C([C@H]1C(=O)N[C@H](C(N[C@@H](CC(N)=O)C(=O)N[C@@H](CSSCCC(=O)N[C@@H](CC=2C=CC(O)=CC=2)C(=O)N1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)NCC(N)=O)=O)CCC(=O)N)C1=CC=CC=C1 NFLWUMRGJYTJIN-NXBWRCJVSA-N 0.000 claims 16
- 229960004281 desmopressin Drugs 0.000 claims 16
- 210000002966 serum Anatomy 0.000 claims 8
- 208000008967 Enuresis Diseases 0.000 claims 4
- 206010046543 Urinary incontinence Diseases 0.000 claims 4
- 239000002552 dosage form Substances 0.000 claims 4
- 239000003937 drug carrier Substances 0.000 claims 4
- 230000027939 micturition Effects 0.000 claims 4
- 239000008194 pharmaceutical composition Substances 0.000 claims 4
- 230000002265 prevention Effects 0.000 claims 4
- 230000001939 inductive effect Effects 0.000 claims 3
- 210000002700 urine Anatomy 0.000 claims 1
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2014133867A JP6341777B2 (ja) | 2014-06-30 | 2014-06-30 | 低用量デスモプレシンを含有する医薬組成物 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2014133867A JP6341777B2 (ja) | 2014-06-30 | 2014-06-30 | 低用量デスモプレシンを含有する医薬組成物 |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2005510644A Division JP5596252B2 (ja) | 2003-11-10 | 2003-11-10 | 低用量デスモプレシンを含有する医薬組成物 |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2015206674A Division JP6523132B2 (ja) | 2015-10-20 | 2015-10-20 | 低用量デスモプレシンを含有する医薬組成物 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2014177492A JP2014177492A (ja) | 2014-09-25 |
| JP2014177492A5 true JP2014177492A5 (enExample) | 2015-05-07 |
| JP6341777B2 JP6341777B2 (ja) | 2018-06-13 |
Family
ID=51697799
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2014133867A Expired - Fee Related JP6341777B2 (ja) | 2014-06-30 | 2014-06-30 | 低用量デスモプレシンを含有する医薬組成物 |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JP6341777B2 (enExample) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP7219712B2 (ja) * | 2016-10-13 | 2023-02-08 | キャタレント・ユーケー・スウィンドン・ザイディス・リミテッド | 膣送達のための凍結乾燥医薬組成物 |
| CN112837756A (zh) * | 2021-01-20 | 2021-05-25 | 中国人民解放军军事科学院军事医学研究院 | 一种从尿排泄曲线推导血浆中化合物暴露特征的方法 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IE60941B1 (en) * | 1986-07-10 | 1994-09-07 | Elan Transdermal Ltd | Transdermal drug delivery device |
| US5849322A (en) * | 1995-10-23 | 1998-12-15 | Theratech, Inc. | Compositions and methods for buccal delivery of pharmaceutical agents |
| AT409081B (de) * | 2000-02-16 | 2002-05-27 | Gebro Pharma Gmbh | Stabile, nasal, oral oder sublingual anwendbare pharmazeutische zubereitung |
| AU2003233118B8 (en) * | 2002-05-07 | 2009-07-30 | Ferring Bv | Desmopressin in an orodispersible dosage form |
-
2014
- 2014-06-30 JP JP2014133867A patent/JP6341777B2/ja not_active Expired - Fee Related
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CY1124052T1 (el) | Δισκιο διασπειρομενο στο στομα περιεχον οιστετρολη | |
| EA201201403A1 (ru) | Очень низкодозированные твердые пероральные лекарственные формы для гзт | |
| WO2008040534A3 (en) | Non-mucoadhesive film dosage forms | |
| JP2010132695A5 (enExample) | ||
| EA201490876A1 (ru) | Ингибиторы рециклинга желчных кислот при лечении холестатических заболеваний печени у детей | |
| PH12018500023A1 (en) | Treatment of cognitive disorders with (r)-7-chloro-n-(quinuclidin-3-yl)benzo[b]thiophene-2-carboxamide and pharmaceutically acceptable salts thereof | |
| HRP20240082T1 (hr) | Inhibitor pde9 s okosnicom imidazopirazinona za liječenje perifernih bolesti | |
| EP2216024A3 (en) | Use of Ranolazine for the treatment of cardiovascular diseases | |
| AU2018256619A1 (en) | Compounds for the treatment of obesity and methods of use thereof | |
| JP2009280621A5 (enExample) | ||
| NZ625592A (en) | Compositions and methods for the treatment of hepatic diseases and disorders | |
| ECSP12011703A (es) | Composiciones farmacéuticas para el tratamiento del cáncer y otras enfermedades o trastornos | |
| WO2011151722A3 (en) | Methods and compositions for oral pharmaceutical therapy | |
| WO2010042701A3 (en) | Corticosteroid compositions for use in treating diseases of the upper and lower airway passages | |
| AR072951A1 (es) | Uso de dronedarona o una sal aceptable farmaceuticamente de esta, para la preparacion de un medicamento para regular el nivel de potasio en la sangre | |
| JP2007119497A5 (enExample) | ||
| NZ719087A (en) | Hydromorphone and naloxone for treatment of pain and opioid bowel dysfunction syndrome | |
| JP2011500589A5 (enExample) | ||
| RU2013157398A (ru) | Композиция | |
| MX2015009546A (es) | Dosificacion aumentada de efavirenz para el tratamiento de cancer. | |
| JP2014177492A5 (enExample) | ||
| EA201071138A1 (ru) | Применение дронедарона для получения лекарственного средства для лечения пациентов с аритмией и с повышенным уровнем креатинина в результате введения дронедарона | |
| MY195054A (en) | Pharmaceutical Composition Comprising Mineralocorticoid Receptor Antagonist and use Thereof | |
| WO2016025671A3 (en) | Treatment of sleep apnea with a combination of a carbonic anhydrase inhibitor and an aldosterone antagonist | |
| PH12014501601A1 (en) | Artemisinin-based combination therapy for treating viral mediated disease |